Primary regulatory

GenoGenix LLC Warning Letter 718739.

U.S. Food and Drug Administration. GenoGenix LLC Warning Letter 718739. Issued 2026-01-20; content current 2026-03-03.

U.S. Food and Drug AdministrationPublished 2026-01-20Accessed 2026-07-12

Open original source

Registry record

Source metadata

Publisher: U.S. Food and Drug Administration
Source type: Primary regulatory
Registry ID: research-amq-05
Source code: AMQ-05

Source usage

Linked from 1 page

Compound

5-Amino-1MQ

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.